Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9504

1.

Depression: An Overlooked Villain in Autoimmune Hepatitis?

Janik MK, Wunsch E, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P.

Hepatology. 2019 Feb 17. doi: 10.1002/hep.30568. [Epub ahead of print]

PMID:
30773711
2.

Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis.

Cazzagon N, Chazouillères O, Corpechot C, El Mouhadi S, Chambenois E, Desaint B, Chaput U, Lemoinne S, Arrivé L.

Clin Res Hepatol Gastroenterol. 2019 Feb 13. pii: S2210-7401(19)30031-2. doi: 10.1016/j.clinre.2019.01.003. [Epub ahead of print]

PMID:
30772328
3.

How to treat Sjögren's syndrome.

Price EJ, Baer AN.

Rheumatology (Oxford). 2019 Feb 15. pii: key363. doi: 10.1093/rheumatology/key363. [Epub ahead of print]

PMID:
30770917
4.

Gut microbiota in liver disease: Too much is harmful, nothing at all is not helpful either.

Hartmann P, Chu H, Duan Y, Schnabl B.

Am J Physiol Gastrointest Liver Physiol. 2019 Feb 15. doi: 10.1152/ajpgi.00370.2018. [Epub ahead of print]

PMID:
30767680
5.

Asymptomatic giant cell hepatitis: a subtype of post-infantile giant cell hepatitis?

Zenda T, Araki I, Sasaki M.

Clin J Gastroenterol. 2019 Feb 14. doi: 10.1007/s12328-019-00950-6. [Epub ahead of print]

PMID:
30767175
6.

Cholangiocarcinoma is associated with a raised enhanced liver fibrosis (ELF) score independent of primary sclerosing cholangitis.

Saffioti F, Roccarina D, Vesterhus M, Hov JR, Rosenberg W, Pinzani M, Pereira SP, Boberg KM, Thorburn D.

Eur J Clin Invest. 2019 Feb 14:e13088. doi: 10.1111/eci.13088. [Epub ahead of print]

PMID:
30762236
7.

Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.

Santiago P, Schwartz I, Tamariz L, Levy C.

Aliment Pharmacol Ther. 2019 Feb 13. doi: 10.1111/apt.15157. [Epub ahead of print] Review.

PMID:
30761563
8.

Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications.

Czaja AJ.

Aliment Pharmacol Ther. 2019 Feb 13. doi: 10.1111/apt.15173. [Epub ahead of print] Review.

PMID:
30761559
9.

Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals.

Fleischer-Stępniewska K, Rymer W, Inglot MS, Zalewska M, Knysz B, Inglot M.

Pol Arch Intern Med. 2019 Feb 13. doi: 10.20452/pamw.4442. [Epub ahead of print] No abstract available.

10.

Bone Health in Patients With Liver Diseases.

Danford CJ, Trivedi HD, Bonder A.

J Clin Densitom. 2019 Jan 18. pii: S1094-6950(18)30253-1. doi: 10.1016/j.jocd.2019.01.004. [Epub ahead of print] Review.

PMID:
30744928
11.

Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.

Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, Inderson A, van Hoek B, Rodriguez Girondo MDM, Maljaars PWJ.

Aliment Pharmacol Ther. 2019 Feb 10. doi: 10.1111/apt.15148. [Epub ahead of print] Review.

PMID:
30740723
12.

Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis.

Honda A, Tanaka A, Kaneko T, Komori A, Abe M, Inao M, Namisaki T, Hashimoto N, Kawata K, Takahashi A, Ninomiya M, Kang JH, Arakawa M, Yamagiwa S, Joshita S, Umemura T, Sato K, Kaneko A, Kikuchi K, Itakura J, Nomura T, Kakisaka K, Fujii H, Kawada N, Takikawa Y, Masaki T, Ohira H, Mochida S, Yoshiji H, Iimuro S, Matsuzaki Y, Takikawa H; Japan PBC Study Group (JPBCSG).

Hepatology. 2019 Feb 8. doi: 10.1002/hep.30552. [Epub ahead of print]

PMID:
30737815
13.

IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury.

Feng XX, Chi G, Wang H, Gao Y, Chen Q, Ru YX, Luo ZL, Yan W, Li PY, Liu M, Feng ZH, Tian DA.

Int Immunopharmacol. 2019 Feb 5;69:184-193. doi: 10.1016/j.intimp.2019.01.037. [Epub ahead of print]

PMID:
30735937
14.

Autotaxin, Bile Acid Profile and Effect of IBAT Inhibition in Primary Biliary Cholangitis Patients with Pruritus.

Hegade VS, Pechlivanis A, McDonald JA, Rees D, Corrigan M, Hirschfield GM, Taylor-Robinson SD, Holmes E, Marchesi JR, Kendrick S, Jones DE.

Liver Int. 2019 Feb 8. doi: 10.1111/liv.14069. [Epub ahead of print]

PMID:
30735608
15.

Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.

Mosher V, Swain M, Pang J, Kaplan G, Sharkey K, MacQueen G, Goodyear BG.

PLoS One. 2019 Feb 8;14(2):e0211906. doi: 10.1371/journal.pone.0211906. eCollection 2019.

16.

In vivo 1 H MRS of human gallbladder bile in understanding the pathophysiology of primary sclerosing cholangitis (PSC): Immune-mediated disease versus bile acid-induced injury.

Mohajeri S, Bezabeh T, Ijare OB, King SB, Thomas MA, Minuk G, Lipschitz J, Kirkpatrick I, Micflikier AB, Summers R, Smith ICP.

NMR Biomed. 2019 Feb 8:e4065. doi: 10.1002/nbm.4065. [Epub ahead of print]

PMID:
30735273
17.

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

Allegretti JR, Kassam Z, Carrellas M, Mullish BH, Marchesi JR, Pechlivanis A, Smith M, Gerardin Y, Timberlake S, Pratt DS, Korzenik JR.

Am J Gastroenterol. 2019 Jan 31. doi: 10.14309/ajg.0000000000000115. [Epub ahead of print]

PMID:
30730351
18.

Primary Sclerosing Cholangitis.

Rawla P, Samant H.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Dec 19.

19.

Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management.

Fricker ZP, Lichtenstein DR.

Dig Dis Sci. 2019 Feb 6. doi: 10.1007/s10620-019-05484-y. [Epub ahead of print] Review.

PMID:
30725292
20.

Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 knockout mice via let-7 microRNA.

McDaniel K, Wu N, Zhou T, Huang L, Sato K, Venter J, Ceci L, Chen D, Ramos-Lorenzo S, Invernizzi P, Bernuzzi F, Wu C, Francis H, Glaser S, Alpini G, Meng F.

Hepatology. 2019 Feb 5. doi: 10.1002/hep.30542. [Epub ahead of print]

PMID:
30723922

Supplemental Content

Loading ...
Support Center